NCMA-CMA action - Certified Medical Assistant Updated: 2024
|Pass4sure NCMA-CMA dumps real question bank
Exam Code: NCMA-CMA Certified Medical Assistant action January 2024 by Killexams.com team
NCMA-CMA Certified Medical Assistant
The NCMA-CMA (National Certified Medical Assistant) exam is designed to assess the knowledge and skills of individuals aspiring to become certified medical assistants. This exam evaluates their understanding of medical assisting principles, clinical and administrative tasks, patient care, and medical knowledge. The following description provides an overview of the NCMA-CMA exam.
Number of Questions and Time:
The NCMA-CMA exam typically consists of approximately 200 multiple-choice questions. The exact number of questions may vary. Candidates are given 3 hours (180 minutes) to complete the exam. The passing score is typically set by the certifying organization and may vary depending on the exam version and updates.
To prepare for the NCMA-CMA exam, candidates can enroll in training programs that cover the key Topics and competencies required for medical assisting. These courses provide a comprehensive understanding of medical assisting principles, clinical and administrative tasks, patient care, and medical knowledge. The course outline may include the following topics:
1. Medical Assisting Principles:
- Medical ethics and legal issues in healthcare
- Professionalism and communication in healthcare settings
- Medical terminology and documentation
- Healthcare laws and regulations
2. Clinical Tasks:
- Patient intake and assessment
- Vital signs measurement and documentation
- Assisting with physical examinations and procedures
- Phlebotomy and specimen collection
- Pharmacology and medication administration
3. Administrative Tasks:
- Scheduling appointments and managing patient records
- Billing and coding procedures
- Health insurance and claims processing
- Electronic health records (EHR) management
- Office management and inventory control
4. Patient Care:
- Infection control and safety procedures
- Patient education and counseling
- Assisting with medical emergencies
- CPR and basic life support techniques
- Cultural competence and patient advocacy
The NCMA-CMA exam aims to evaluate the candidate's knowledge and skills in medical assisting. The exam objectives include the following:
1. Demonstrating understanding of medical assisting principles and professional conduct.
2. Performing clinical tasks, such as patient assessment, vital signs measurement, and specimen collection.
3. Managing administrative tasks, including scheduling, billing, and medical records management.
4. Providing patient care and ensuring safety and infection control.
5. Applying medical knowledge and assisting healthcare providers in various procedures.
6. Adhering to legal and ethical standards in medical assisting practice.
The NCMA-CMA exam syllabus covers the key Topics and competencies required to excel in medical assisting. The syllabus includes the following areas of study:
- Medical assisting principles and professional conduct
- Clinical tasks and patient care
- Administrative tasks and office management
- Medical knowledge and procedures
- Legal and ethical considerations in medical assisting
|Certified Medical Assistant
Medical Certified action
Other Medical examsCRRN Certified Rehabilitation Registered Nurse
CCRN Critical Care Register Nurse
CEN Certified Emergency Nurse
CFRN Certified Flight Registered Nurse
CGFNS Commission on Graduates of Foreign Nursing Schools
CNA Certified Nurse Assistant
CNN Certified Nephrology Nurse
CNOR Certified Nurse Operating Room
DANB Dental Assisting National Board
EMT Emergency Medical Technician
EPPP Examination for Professional Practice of Psychology
FPGEE Foreign Pharmacy Graduate Equivalency
NBCOT National Board for Certification of Occupational Therapists - 2023
NCBTMB National Certification Board for Therapeutic Massage & Bodywork
NET Nurse Entrance Test
NPTE National Physical Therapy Examination
OCN Oncology Certified Nurse - 2023
PANCE Physician Assistant National Certifying
VTNE Veterinary Technician National Examination (VTNE)
CNS Clinical Nurse Specialist
NBRC The National Board for Respiratory Care
AHM-540 AHM Medical Management
AACN-CMC Cardiac Medicine Subspecialty Certification
AAMA-CMA AAMA Certified Medical Assistant
ABEM-EMC ABEM Emergency Medicine Certificate
ACNP AG - Acute Care Nurse Practitioner
AEMT NREMT Advanced Emergency Medical Technician
AHIMA-CCS Certified Coding Specialist (CPC) (ICD-10-CM)
ANCC-CVNC ANCC (RN-BC) Cardiac-Vascular Nursing
ANCC-MSN ANCC (RN-BC) Medical-Surgical Nursing
ANP-BC ANCC Adult Nurse Practitioner
APMLE Podiatry and Medical
BCNS-CNS Board Certified Nutrition Specialis
BMAT Biomedical Admissions Test
CCN CNCB Certified Clinical Nutritionist
CCP Certificate in Child Psychology
CDCA-ADEX Dental Hygiene
CDM Certified Dietary Manager
CGRN ABCGN Certified Gastroenterology Registered Nurse
CNSC NBNSC Certified Nutrition Support Clinician
COMLEX-USA Osteopathic Physician
CPM Certified Professional Midwife
CRNE Canadian Registered Nurse Examination
CVPM Certificate of Veterinary Practice Management
DAT Dental Admission Test
DHORT Discover Health Occupations Readiness Test
DTR Dietetic Technician Registered
FNS Fitness Nutrition Specialist
MHAP MHA Phlebotomist
MSNCB MSNCB Medical-Surgical Nursing Certification
NAPLEX North American Pharmacist Licensure Examination
NCCT-TSC NCCT Technician in Surgery
NCMA-CMA Certified Medical Assistant
NCPT National Certified Phlebotomy Technician (NCPT)
NE-BC ANCC Nurse Executive Certification
NNAAP-NA NNAAP Nurse Aide
NREMT-NRP NREMT National Registered Paramedic
NREMT-PTE NREMT Paramedic Trauma Exam
OCS Ophthalmic Coding Specialist
PANRE Physician Assistant National Recertifying Exam
PCCN AACN Progressive Critical Care Nursing
RDN Registered Dietitian
VACC VACC Vascular Access
WHNP Women Health Nurse Practitioner
AACD American Academy of Cosmetic Dentistry
RPFT Registered Pulmonary Function Technologist
ACLS Advanced Cardiac Life Support - 2023
GP-Doctor General Practitioner (GP) Doctor
GP-MCQS Prometric MCQS for general practitioner (GP) Doctor
INBDE Integrated National Board Dental Examination (Day 1 exam)
Podiatry-License-Exam-Part-III Podiatry License exam Part III - 2023
|We supply completely tested NCMA-CMA NCMA-CMA dumps with genuine Questions Answers that are recently required for Passing NCMA-CMA test. We truly enable individuals to enhance their knowledge to remember the Q&A and guarantee. It is a best decision to speed up your position as an expert in the Industry.
NCMA-CMA Real Questions
NCMA-CMA Practice Test
NCMA-CMA dumps free
Certified Medical Assistant
What would be the most likely explanation if an elderly patient suddenly has an onset of confusion, with no
previous disorders or symptoms?
A. Urinary Tract Infection
Which of the following symptoms would a patient exhibit that could be indicative of cerebral edema?
A. Abdominal pain
C. Seizures and coma
D. Normal vision
A paramedic informs the medical assistant that a patient has had a cardiac arrest.
What does this mean?
A. Irregular heartbeat
B. Blood flow interference to the heart
C. Variation in the rhythm of the heartbeat
D. Sudden stoppage of the heartbeat
The pharmaceutical abbreviation "qid" means ____________.
A. every hour
B. every day
C. four times a day
D. every week
If medication has been orderd by a physician to be taken "pc", it should be given __________.
A. Before meals
B. At hours sleep
C. After meals
D. Every four hours
The pharmaceutical abbreviation "bid" means _____________.
A. once a day
B. twice a day
C. once a week
D. twice a week
If medication of a patient or resident is indicated as PRN, it is given __________.
A. Once a day
B. When necessary
C. By mouth only
D. To discontinue use
All of the following are narcotic or narcotic-like analgesics, except __________.
Which of the following classifications of medications would be helpful in treating the patient that is complaining of
A. Beta blockers
Which of the following reactions should the patient expect to experience if a patient is prescribed a diabetic agent
such as Metformin?
A. An increase in their blood glucose level
B. A decrease in their blood pressure
C. A decrease in their blood glucose level
Which medication would typically be ordered to help a patient to get rid of excess fluid in their lungs?
A patient is diagnosed with a blood clot in their left lower leg and is hospitalized.
Which of the following would more than likely be prescribed for the patient per intravenous solution?
Which of the following would be considered a muscle relaxant that might be ordered for a patient with back pain?
C. Bismuth subsalicylate
Which of the following should a patient be able to eat if the physician prescribes a low-fat diet?
A. Whole milk
B. Chicken with skin attached
C. Cake with icing
D. Boneless, skinless chicken breast
Which would be considered the correct percentage of nutrient intake by the Dietetic Association for a person's
protein intake every 24 hours?
D. None of the above
Which describes the body's ability to maintain its normal state?
For More exams visit https://killexams.com/vendors-exam-list
Kill your exam at First Attempt....Guaranteed!
MONTGOMERY, Ala. (AP) — A judge has temporarily blocked Alabama from issuing licenses to medical marijuana facilities amid an ongoing legal battle over how the state selected the winning companies.
Montgomery Circuit Judge James Anderson issued a temporary restraining order late Wednesday to stop the Alabama Medical Cannabis Commission from issuing licenses for “integrated” facilities that grow, transport and sell medical marijuana. The coveted licenses will be on hold while he hears a challenge to the selection process.
Companies that were not selected to receive one of the five available integrated licenses have challenged the selection process, saying the commission violated its own rules when selecting winners. The commission has attempted to award the licenses three times and rescinded the first two selections during the legal dispute.
Anderson said he is sympathetic to concerns about delaying the availability of medical marijuana but said a pause on the licenses is merited.
“While the court understands those parties’ frustrations, the court also notes that all three rounds of awards have been challenged as legally infirm: the first two rounds of awards were abandoned by action of the Commission itself, and now there is a serious question as to whether the third round is also invalid,” Anderson wrote.
The restraining order is the latest development in a legal battle that has plagued the start of Alabama’s medical marijuana program. Alabama lawmakers voted to allow medical marijuana in the state in 2021. Commission officials are aiming to make the products available in 2024 after a series of delays.
“We remain determined and hopeful that the availability of medical cannabis products, recommended by certified physicians to qualified Alabama patients, is right around the corner,” Alabama Medical Cannabis Commission Director John McMillan said in a statement.
The Wednesday order only affects the licenses for the facilities that perform multiple functions from “seed to sale.” The judge last week put a hold on licenses for dispensaries in order to hear a similar challenge. The commission has issued licenses for growers, processors, transportation companies and laboratory testing.
McMillan said the delay on having any licensed dispensaries to sell medical marijuana products also delays the ability of Alabama doctors to get certified to recommend medical cannabis to patients. He said the Alabama Board of Medical Examiners requires the issuance of at least one cultivator, processor, secure transporter, and dispensary license before the board will issue medical cannabis certification permits to physicians.
“We remain hopeful that the Court will swiftly permit the issuance of all licenses awarded by the Commission,” McMillan said.
A lawsuit against Saint-Gobain, the French manufacturing company accused of contaminating drinking water in towns in southern New Hampshire with harmful PFAS chemicals, has entered a new phase after a federal judge said part of the case could be managed as a class action.
Under the decision, thousands of residents who live or have lived near the Merrimack facility since 2016 could be part of the class action. The class could include almost 9,000 households within Merrimack and 382 homes in Bedford within the Merrimack Village District Water Works service area, and 1,200 homes with private wells in the area.
PFAS are a class of man-made chemicals that have been used for decades in a variety of consumer products and have been linked torisks to human health like increased risk for certain kinds of cancers.
Elevated levels of those chemicals were discovered around Saint-Gobain’s Merrimack facility in 2016. The company knew about elevated PFAS levels in their emissions since at least 2004.
The company has provided bottled water and alternative drinking water to residents affected by contamination through a consent decree with the state of New Hampshire. They announced they were closing their Merrimack facility last year.
A class action lawsuit brought by people living near the Saint Gobain manufacturing facility in Merrimack who say they were exposed to PFOA, one of many PFAS chemicals, was filed in 2016.
Judge Joseph Laplante’s Dec. 29 decision splits that case into two phases. In the first, the court would determine whether Saint-Gobain’s Merrimack facility was liable for contamination for nearby residents as a whole, instead of for each individual case.
The second phase will determine how individuals may be compensated for the contamination on a case-by-case basis.
Laplante denied class certification for the claim in the lawsuit that Saint-Gobain caused a “nuisance,” saying that whether Saint-Gobain interfered with each person’s use and enjoyment of their property would need to be determined on an individual basis.
But he certified the class for the purpose of the claims that Saint-Gobain trespassed on residents’ land by causing PFAS chemicals to enter without their permission and that the company acted negligently by emitting PFAS, not investigating and mitigating contamination adequately, and not warning residents about the risks of the chemicals.
Whether Saint-Gobain is liable for emitting the chemicals, how much they foresaw the consequences, and whether they adequately investigated, mitigated, and warned people about them can be determined for all residents together, the judge said.
Mindi Messmer, a former state lawmaker who has called for more accountability for Saint-Gobain over their PFAS emissions, said the decision is a victory for those who may have been affected by the chemicals.
“This is a big step in that the court is signaling that there is at least some validity to the claims made by the plaintiffs,” she said.
According to court documents, the plaintiffs are seeking compensation for non-economic losses, like the loss of enjoyment of their property, and compensation for economic losses related to the decreased value of their properties and the cost of mitigating contamination.
Experts for the plaintiffs found that damages in the area addressed in the lawsuit would be around $578 million for losses in property value and $2.6 million for those who switched from private wells to municipal water.
Last March, the New Hampshire Supreme Court decided that people exposed to toxins could not recover the cost of medical testing from polluters if they’re not currently sick in a ruling connected to the case.
That came as a disappointment to Laurene Allen, who started Merrimack Citizens for Clean Water to advocate for those affected by PFAS contamination. She said the Supreme Court decision weakened the class action suit.
“When you talk to people you hear about a health condition, then another health condition, then another health condition,” she said. “For many people, you’re watching what’s happening around you, and you know why it’s happening, and no one’s doing anything about it, and your health isn’t properly supported in terms of monitoring. That’s why medical monitoring is so important.”
But despite the lack of medical monitoring cost recovery, Allen said the certification of the class in the lawsuit was validating. And, she said, she hopes the case goes to trial.
Two other class action lawsuits against Saint-Gobain for PFAS pollution – one in Hoosick Falls, N.Y., and one in Bennington, Vt. – ended in settlements in which the company did not admit wrongdoing or liability.
“I would love to see this go to trial and that they truly be held accountable for the harm that they caused,” Allen said. “What they have never once been held accountable for is the harm they have caused, the harm to human health and the forever contamination of our environment.”
This policy identifies the conditions under which eligible Faculty or Professional Staff Members may take a medical leave of absence not covered under the Federal Family Medical Leave Act of 1993 (FMLA).
This policy applies to all benefit eligible Faculty and Professional Staff Members, excluding any Professional Staff Members governed by language in their collective bargaining unit agreement.
Implementation of this policy is the responsibility of the Department of Human Resources in conjunction with the Designated Third-Party Administrator.
The Executive Vice President, Treasurer and Chief Operating Officer is the Drexel University official responsible for the administration of this policy.
Benefit Eligible refers to full-time or part-time Drexel Faculty and Professional Staff Members who are eligible to receive Drexel paid benefits (e.g. medical coverage, leave accrual, etc.). Full-time Faculty working 12 or more credit hours in three or more quarters (or equivalent workload) and full-time Professional Staff Members are regularly scheduled to work 40 hours per week. Part-time Faculty with at least a 50 percent appointment and part-time Professional Staff Members are regularly scheduled to work at least 20 hours per week but less than 40.
Designated Third-Party Administrator is the Drexel-chosen provider for Non-FMLA Medical Leave administration.
Faculty Member is defined as an individual employed by Drexel University in a tenured, tenure-track, non-tenured track or adjunct position who teaches within any college, school, center or institute in the University. A Faculty Member is deemed to be exempt under the provisions of the Fair Labor Standards Act (FLSA) and/or applicable state law.
Health Care Provider is defined as a doctor, podiatrist, dentist, clinical psychologist, optometrist, nurse practitioner, nurse midwife, clinical social worker, physician assistant, Christian Science practitioner or a chiropractor.
Professional Staff Member is defined as an individual employed in any non-faculty category by Drexel University, including an individual who is deemed to be either exempt or non-exempt under the provisions of the Fair Labor Standards Act (FLSA) and/or applicable state law.
Serious Health Condition is defined as an illness, injury or impairment, or physical or mental condition that involves either inpatient care or continuing care by a health-care provider. Continuing care can include:
Spouse refers to any individual who is lawfully married to an employee.
Request for Medical Leave of Absence
Duration of Medical Leave
Compensation for Professional Staff Members when using Paid Leave
Compensation for Faculty Members
Faculty Member Teaching and Workload
Benefits During Leave
Return from Leave
AT-WILL EMPLOYMENT NOT AFFECTED
Two law firms in New York announced the filing of a class action lawsuit by investors against Inspire Medical Systems (NYSE:INSP).
Bragar Eagel & Squire, P.C., and Bernstein Liebhard LLP filed on behalf of persons or entities who purchased or otherwise acquired Inspire Medical common stock between May 3, 2023, and Nov. 7, 2023.
The Minneapolis-based company develops minimally invasive implantable products for treating obstructive sleep apnea. It offers an alternative to the traditional CPAP machines made by the likes of Philips and ResMed. Inspire Medical’s reputation has grown over the past several years as Philips dealt with a massive CPAP recall and people moved away from that method of treatment.
Outlining the class action allegations against Inspire Medical
According to the law firms, Inspire introduced a pilot program in 2022. In this program, the company’s advisor care program team could directly access doctors’ electronic schedules and schedule appointments online.
Throughout the period outlined in the class action, Inspire allegedly touted the program’s effectiveness. The suits say the company boasted a 30% improvement in physician appointments. By August 2023, the suit alleges Inspire claimed more than 60 centers used the tool.
The suit alleges that during the May-August period, Inspire misled investors and/or failed to disclose key outcomes. Among the allegations, the firms say that customers encountered challenges with previous authorization submissions and scheduling appointments, despite the acceleration program. The slowdown in authorization submissions from these challenges allegedly led to a shortfall of hundreds of implant procedures.
As a result, the law firms say, Inspire’s positive statements about financial guidance, business, operations and prospects “were materially false and misleading and/or lacked a reasonable basis at all relevant times.”
Inspire’s third-quarter earnings — announced on Nov. 7 — included revenues that fell shy of expectations on Wall Street. The company also reported a decline in prior authorization submissions for patients seeking Inspire therapy. It also said it started to “track” problems with the acceleration program no later than the second quarter of 2023.
In response to the earnings, shares of INSP fell approximately 20% from $161.74 at close on Nov. 7 to $129.95 on Nov. 8. The stock has since rebounded, though, sitting at a share price of $201 before the market opened today, Dec. 27.
An Inspire spokesperson shared the following response to a request for comment:
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Inspire Medical To Contact Him Directly To Discuss Their Options
If you suffered losses exceeding $100,000 investing in Inspire Medical stock or options between May 3, 2023 and November 7, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for additional information: www.faruqilaw.com/INSP.
There is no cost or obligation to you.
New York, New York--(Newsfile Corp. - December 29, 2023) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Inspire Medical Systems, Inc. ("Inspire Medical" or the "Company") (NYSE: INSP) and reminds investors of the February 20, 2024 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
Faruqi & Faruqi is a leading minority and Woman-owned national securities law firm with offices in New York, Pennsylvania, California and Georgia.
As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (1) despite the Acceleration Program, customers were encountering challenges with the prior authorization submission process, including with the scheduling of appointments; (2) a slowdown in prior authorization submissions arising from these challenges led to a shortfall of hundreds of procedures to implant the Company's OSA device; and (3) as a result, Defendants' positive statements about the Company's financial guidance, business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.
The truth emerged after the close of markets on November 7, 2023, when the Company announced disappointing earnings results for the third quarter of 2023, including "a decline in prior authorization submissions for patients seeking Inspire therapy." Inspire Medical further admitted it had started to "track" problems with the Acceleration Program no later than the second quarter of 2023, the Company "had strong confirmation" of the problems with the Acceleration Program, and the Company "realized we needed to take some corrective action."
In response to this news, shares of Inspire Medical declined approximately 20%, from a closing price of $161.74 per share on November 7, 2023, to a closing price of $129.95 per share on November 8, 2023.
The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not.
Faruqi & Faruqi, LLP also encourages anyone with information regarding Inspire Medical's conduct to contact the firm, including whistleblowers, former employees, shareholders and others.
Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not certain or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/192404
Community Action of Etowah County Inc. will begin scheduling appointments for its regular and crisis low-income heating programs on Jan. 17.
Office hours are 8 a.m. to 5 p.m. Monday through Friday; the office is closed from noon to 1 p.m. for lunch. Only applicants with pending applications will be served on Fridays.
Applicants are eligible if the household heats with natural or butane gas, or is totally electric, and applicants meet Fiscal Year 2024 eligibility requirements.
The Regular Heating Program provides general heating assistance to eligible households that meet the guidelines set by the Alabama Department of Economic and Community Affairs.
The Crisis Heating Program provides assistance to households with an energy-related crisis. Any household member with a medical situation caused or aggravated by extreme heat or cold may apply for crisis assistance, with verification by a physician or nurse on the agency-provided “Physician/Nurse Medical Statement.”
Households must meet all points of eligibility before assistance can be awarded. Documents provided must be for the month before the date of an appointment.
The following documents are required and may be submitted through fax or email:
Household members who are unemployed and currently do not have income must complete a "Declaration of Household Income" form provided by Community Action of Etowah County.
Employed household members must provide check stubs as verification of income. Bank statements cannot be used to verify income from SS or SSI benefits. If a person in the household has applied for SS or SSI and the status is pending, a letter from the Social Security office or a representation letter from any attorney is required. Custody claims must be Checked with legal documentation, such as guardianship declarations.
Residents who live in assisted living or public housing projects, and are responsible for out-of-pocket payments for utility bills, may qualify for the regular and crisis utility assistance program. In addition to all other eligibility requirements, households must provide proof of out-of-pocket "utility allowance" and "utility reimbursement" payments (lease agreement/tenant income certification.
Fiscal Year 2024 Monthly Income eligibility requirements are:
For more information, contact Community Action of Etowah County at 256-546-9271.
This article originally appeared on The Gadsden Times: Community Action of Etowah County offers heating assistance
NCMA-CMA test | NCMA-CMA health | NCMA-CMA candidate | NCMA-CMA course outline | NCMA-CMA helper | NCMA-CMA test prep | NCMA-CMA exam | NCMA-CMA course outline | NCMA-CMA mock | NCMA-CMA education |
Killexams exam Simulator
Killexams Questions and Answers
Killexams Exams List